Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Synergistic Dual OXPHOS Blockade: LRPPRC Inhibition Plus Das
2026-05-13
This study demonstrates that combining LRPPRC inhibition with dasatinib achieves robust, synergistic anti-tumor activity by coordinately disrupting mitochondrial and nuclear-encoded OXPHOS gene expression. These findings refine our understanding of tumor metabolic dependencies and inform new, rational combination strategies for targeting LRPPRC-high cancers.
-
Technical Guidance: HyperScribe™ T7 High Yield Cy3 RNA Label
2026-05-13
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus addresses the need for high-yield, fluorescently labeled RNA probes for research workflows such as in situ hybridization and Northern blotting. This kit is not validated for diagnostic or therapeutic applications, and its use should be limited to fluorescence-based RNA detection in research settings.
-
Deferasirox Fe3+ Chelate: Mechanistic Insights and Research
2026-05-12
Explore the advanced iron chelation mechanism of Deferasirox Fe3+ chelate in chronic anemia models. This article delivers a deep, evidence-based analysis of its molecular action, research applications, and protocol implications—distinct from existing guides.
-
NEXMIF Gene Restoration Ameliorates ASD Phenotypes in Mice
2026-05-12
This study demonstrates that postnatal reintroduction of the human NEXMIF gene into Nexmif knockout mice rescues key deficits in gene transcription, neuronal maturation, and autistic-like behaviors. These findings provide critical proof-of-concept for gene therapy approaches targeting neurodevelopmental disorders marked by X-linked NEXMIF deficiency.
-
Jasplakinolide: Precision Actin Polymerization for Translati
2026-05-11
This thought-leadership article explores how Jasplakinolide, a potent actin polymerization inducer from APExBIO, is redefining the experimental and translational toolkit for cytoskeletal research. By integrating mechanistic insights, protocol optimization, and competitive intelligence, we offer strategic guidance for translational researchers seeking to bridge basic cell biology with antifungal and antiproliferative discovery. We connect this discussion to landmark work in chemical genetics, highlighting how targeted small molecules such as bestatin have driven innovation in parallel fields, and we position Jasplakinolide as a critical enabler in the next wave of cytoskeletal dynamics studies.
-
SFTSV NSs Activate NLRP1/CARD8 Inflammasomes by Disrupting D
2026-05-11
This study reveals a novel mechanism by which SFTSV non-structural protein (NSs) activates the NLRP1 and CARD8 inflammasomes in primary human cells by disrupting DPP9-mediated ternary complexes. The findings elucidate a critical checkpoint in innate immunity and suggest broader relevance for research on dipeptidyl peptidase inhibition and inflammasome regulation.
-
ABT-199 (Venetoclax): Precision Bcl-2 Inhibition in Apoptosi
2026-05-10
ABT-199 (Venetoclax) empowers researchers with highly selective and potent Bcl-2 inhibition, enabling cleaner, more reliable apoptosis assays in hematologic malignancy models. This guide translates recent mechanistic breakthroughs and hands-on troubleshooting into actionable workflows for maximizing experimental rigor.
-
Distinct Mechanisms of Chuanxiong Cortex and Pith in CHD The
2026-05-09
This study applied SPME-GC×GC-MS and network pharmacology to differentiate the volatile components and molecular targets of Ligusticum chuanxiong’s rhizome cortex and pith in coronary heart disease (CHD) prevention. The results highlight tissue-specific bioactive compounds and signaling pathways, enhancing the precision of herbal interventions in CHD.
-
Oligo (dT) 25 Beads: Reliable Magnetic mRNA Purification (SK
2026-05-09
This article provides an evidence-based guide for biomedical researchers and lab technicians seeking reproducible eukaryotic mRNA isolation using Oligo (dT) 25 Beads (SKU K1306). By addressing real-world protocol optimization and vendor selection challenges, it demonstrates how these superparamagnetic beads streamline molecular workflows and support high-integrity downstream applications.
-
Cell-to-Cell Transfer of Immunoproteasomes via Extracellular
2026-05-08
This study demonstrates, for the first time, that non-constitutive (immuno-)proteasomes can be transmitted between mammalian cells through extracellular vesicles. The findings offer new insights into immune regulation and open technical avenues for exploring immunoproteasome inhibition in disease contexts.
-
Safe DNA Gel Stain (SKU A8743): Reliable Visualization for M
2026-05-07
This article provides scenario-driven, evidence-based guidance for biomedical researchers and lab technicians seeking reliable, sensitive, and safer alternatives for DNA and RNA gel staining. Leveraging SKU A8743, Safe DNA Gel Stain, it addresses practical laboratory challenges through quantitative data and validated protocols, emphasizing reproducibility and workflow safety.
-
Lanabecestat (AZD3293): Precision BACE1 Inhibition in Alzhei
2026-05-07
Explore how Lanabecestat (AZD3293) enables controlled, synaptic-sparing inhibition of BACE1 in Alzheimer’s disease research. This article uniquely bridges mechanistic insights with practical assay guidance, informed by recent evidence.
-
DHA Supplementation Mitigates LPS-Induced Fetal Growth Restr
2026-05-06
This study demonstrates that maternal docosahexaenoic acid (DHA) supplementation during pregnancy protects against lipopolysaccharide (LPS)-induced fetal growth restriction (FGR) in mice. By suppressing inflammatory signaling and supporting gut-placenta interactions, DHA offers a targeted nutritional approach to limiting adverse pregnancy outcomes associated with maternal inflammation.
-
HyperScript First-Strand cDNA Synthesis Kit: Precision for C
2026-05-06
The HyperScript™ First-Strand cDNA Synthesis Kit enables robust, high-fidelity cDNA synthesis from total or poly(A)+ RNA, excelling even with challenging secondary structures and low-abundance transcripts. Its engineered reverse transcriptase and advanced primer options empower sensitive PCR and qPCR applications, making it indispensable for gene expression studies in oncology and beyond.
-
Reliable Cell Assays with HyperFluor™ 594 Goat Anti-Rabbit I
2026-05-05
This article addresses common laboratory challenges in immunodetection workflows, focusing on how the HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody (SKU K3305) ensures reproducibility and sensitivity for cell viability, proliferation, and cytotoxicity assays. Scenario-driven Q&As provide practical, evidence-based guidance for researchers seeking robust secondary antibody solutions.